Cargando…

Nanoparticle-Mediated Delivery of Satraplatin to Overcome Cisplatin Drug Resistance

Drug resistance and cancer metastasis are the major obstacles for widely used platinum-based chemotherapy. It is acknowledgement that the decreasing intracellular accumulation of anticancer drugs and increasing sulfur-binding detoxification are two major mechanisms related to drug resistance. Herein...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Xiaohan, Yang, Qiang, Qi, Ruogu, Yan, Lesan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10381687/ https://www.ncbi.nlm.nih.gov/pubmed/37504882 http://dx.doi.org/10.3390/jfb14070387

Ejemplares similares

Satraplatin in the treatment of hormone-refractory metastatic prostate cancer
por: Armstrong, Andrew J, et al.
Publicado: (2007)

Biomarker Development Trial of Satraplatin in Patients with Metastatic Castration-Resistant Prostate Cancer
por: Liaw, Bobby C, et al.
Publicado: (2022)

An open-label, dose-finding study of the combination of satraplatin and gemcitabine in patients with advanced solid tumors
por: Paola, Eugenio Donato Di, et al.
Publicado: (2012)

Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance
por: Yao, Yihan, et al.
Publicado: (2020)

Co-delivery of Gefitinib and chloroquine by chitosan nanoparticles for overcoming the drug acquired resistance
por: Zhao, Liang, et al.
Publicado: (2015)

Co-delivery nanoparticles with characteristics of intracellular precision release drugs for overcoming multidrug resistance
por: Zhang, DanDan, et al.
Publicado: (2017)

Doxorubicin and resveratrol co-delivery nanoparticle to overcome doxorubicin resistance
por: Zhao, Yuan, et al.
Publicado: (2016)

Enhanced efficacy in drug-resistant cancer cells through synergistic nanoparticle mediated delivery of cisplatin and decitabine
por: Parhizkar, M., et al.
Publicado: (2020)

Targeting HNRNPU to overcome cisplatin resistance in bladder cancer
por: Shi, Zhen-duo, et al.
Publicado: (2022)

Smart drug delivery systems to overcome drug resistance in cancer immunotherapy
por: Yi, Wenzhe, et al.
Publicado: (2023)

Combination therapy based on dual-target biomimetic nano-delivery system for overcoming cisplatin resistance in hepatocellular carcinoma
por: Huang, Yufen, et al.
Publicado: (2023)

Mithramycin and Analogs for Overcoming Cisplatin Resistance in Ovarian Cancer
por: Schweer, David, et al.
Publicado: (2021)

Cisplatin liposome and 6-amino nicotinamide combination to overcome drug resistance in ovarian cancer cells
por: Catanzaro, Daniela, et al.
Publicado: (2018)

Sequenced Combinations of Cisplatin and Selected Phytochemicals towards Overcoming Drug Resistance in Ovarian Tumour Models
por: Althurwi, Safiah Ibrahim, et al.
Publicado: (2020)

Nano-Based Drug Delivery and Targeting to Overcome Drug Resistance of Ovarian Cancers
por: McFadden, Melayshia, et al.
Publicado: (2021)

Micheliolide overcomes KLF4-mediated cisplatin resistance in breast cancer cells by downregulating glutathione
por: Jia, Yongsheng, et al.
Publicado: (2015)

Niclosamide (NA) overcomes cisplatin resistance in human ovarian cancer
por: Huang, Linjuan, et al.
Publicado: (2023)

Overcoming cisplatin resistance by mTOR inhibitor in lung cancer
por: Wu, Chunjing, et al.
Publicado: (2005)

Disulfiram Overcomes Cisplatin Resistance in Human Embryonal Carcinoma Cells
por: Schmidtova, Silvia, et al.
Publicado: (2019)

Regulation of glucose and glutamine metabolism to overcome cisplatin resistance in intrahepatic cholangiocarcinoma
por: Yang, So Mi, et al.
Publicado: (2023)

Overcoming the Blood–Brain Barrier: Successes and Challenges in Developing Nanoparticle-Mediated Drug Delivery Systems for the Treatment of Brain Tumours
por: Ferraris, Chiara, et al.
Publicado: (2020)

Gold and Iron Oxide Nanoparticle-Based Ethylcellulose Nanocapsules for Cisplatin Drug Delivery
por: Sathish Kumar, Kannaiyan, et al.
Publicado: (2011)

Organic Anion Transporting Polypeptide 5A1 (OATP5A1) in Small Cell Lung Cancer (SCLC) Cells: Possible Involvement in Chemoresistance to Satraplatin
por: Olszewski-Hamilton, U., et al.
Publicado: (2011)

Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cells
por: Onafuye, Hannah, et al.
Publicado: (2019)

Folate-mediated mitochondrial targeting with doxorubicin-polyrotaxane nanoparticles overcomes multidrug resistance
por: Wang, He, et al.
Publicado: (2014)

Recent advances in access to overcome cancer drug resistance by nanocarrier drug delivery system
por: Sun, Xiangyu, et al.
Publicado: (2023)

Perspectives of nano-carrier drug delivery systems to overcome cancer drug resistance in the clinics
por: Ulldemolins, Anna, et al.
Publicado: (2021)

Magnetic Nanoparticle Mediated Steroid Delivery Mitigates Cisplatin Induced Hearing Loss
por: Ramaswamy, Bharath, et al.
Publicado: (2017)

The Vitamin D Receptor–BIM Axis Overcomes Cisplatin Resistance in Head and Neck Cancer
por: Khamis, Aya, et al.
Publicado: (2022)

Lipid–Saporin Nanoparticles for the Intracellular Delivery of Cytotoxic Protein to Overcome ABC Transporter-Mediated Multidrug Resistance In Vitro and In Vivo
por: Zhang, Guan-Nan, et al.
Publicado: (2020)

Synthesis and Characterization of Quercetin–Iron Complex Nanoparticles for Overcoming Drug Resistance
por: Prestianni, Lucas, et al.
Publicado: (2023)

Nanoparticles of Metal-Organic Cages Overcoming Drug Resistance in Ovarian Cancer
por: Wang, Han, et al.
Publicado: (2019)

TRPV1 inhibition overcomes cisplatin resistance by blocking autophagy-mediated hyperactivation of EGFR signaling pathway
por: Oh, Se Jin, et al.
Publicado: (2023)

pH- and photothermal-driven multistage delivery nanoplatform for overcoming cancer drug resistance
por: Huang, Wenjing, et al.
Publicado: (2019)

Cleavable PEGylation: a strategy for overcoming the “PEG dilemma” in efficient drug delivery
por: Fang, Yan, et al.
Publicado: (2017)

Effective Delivery of siRNA-Loaded Nanoparticles for Overcoming Oxaliplatin Resistance in Colorectal Cancer
por: Zhou, Yue, et al.
Publicado: (2022)

Dual subcellular compartment delivery of doxorubicin to overcome drug resistant and enhance antitumor activity
por: Song, Yan-feng, et al.
Publicado: (2015)

Health Benefits of Modificated Multiplatinum Derivatives as Strategies for Overcoming the Cisplatin Resistance
por: Ivanova, Stefka Achkova, et al.
Publicado: (2023)

Overcoming Physiological Barriers to Nanoparticle Delivery—Are We There Yet?
por: Thomas, Oliver S., et al.
Publicado: (2019)

APR-246 overcomes resistance to cisplatin and doxorubicin in ovarian cancer cells
por: Mohell, N, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_honsn3da3ruf4nunf2ok44v4lu